DE3117756A1 - "theophyllin-tablette" - Google Patents

"theophyllin-tablette"

Info

Publication number
DE3117756A1
DE3117756A1 DE19813117756 DE3117756A DE3117756A1 DE 3117756 A1 DE3117756 A1 DE 3117756A1 DE 19813117756 DE19813117756 DE 19813117756 DE 3117756 A DE3117756 A DE 3117756A DE 3117756 A1 DE3117756 A1 DE 3117756A1
Authority
DE
Germany
Prior art keywords
theophylline
pharmaceutical tablet
tablet according
tablet
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19813117756
Other languages
German (de)
English (en)
Other versions
DE3117756C2 (fr
Inventor
Dana Brooks
Stephen T. David
Claude E. Evansville In. Gallian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE3117756A1 publication Critical patent/DE3117756A1/de
Application granted granted Critical
Publication of DE3117756C2 publication Critical patent/DE3117756C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19813117756 1980-05-06 1981-05-05 "theophyllin-tablette" Granted DE3117756A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (2)

Publication Number Publication Date
DE3117756A1 true DE3117756A1 (de) 1982-04-29
DE3117756C2 DE3117756C2 (fr) 1992-11-26

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813117756 Granted DE3117756A1 (de) 1980-05-06 1981-05-05 "theophyllin-tablette"

Country Status (17)

Country Link
AT (1) AT380789B (fr)
AU (1) AU549299B2 (fr)
CA (1) CA1165241A (fr)
CY (1) CY1368A (fr)
DE (1) DE3117756A1 (fr)
DK (1) DK155976C (fr)
FI (1) FI811356L (fr)
FR (1) FR2484253A1 (fr)
GB (1) GB2078518B (fr)
HK (1) HK4288A (fr)
IE (1) IE51157B1 (fr)
IT (1) IT1209867B (fr)
KE (1) KE3722A (fr)
LU (1) LU83342A1 (fr)
NL (1) NL8102168A (fr)
SE (1) SE452550B (fr)
SG (1) SG30987G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (fr) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Pharm. Pharmacol, 1965, 17, S. 698-702 *
RITSCHEL W.A.: Die Tablette, Bd. 7, 1966, S. 63-67 *

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
CA1165241A (fr) 1984-04-10
KE3722A (en) 1987-04-30
FI811356L (fi) 1981-11-07
ATA202081A (de) 1985-12-15
HK4288A (en) 1988-01-29
IE51157B1 (en) 1986-10-15
IT8148406A0 (it) 1981-05-06
AU549299B2 (en) 1986-01-23
DK200181A (da) 1981-11-07
AT380789B (de) 1986-07-10
DK155976C (da) 1989-10-30
LU83342A1 (fr) 1982-01-20
FR2484253B1 (fr) 1983-06-03
FR2484253A1 (fr) 1981-12-18
GB2078518A (en) 1982-01-13
NL8102168A (nl) 1981-12-01
GB2078518B (en) 1984-04-11
SE452550B (sv) 1987-12-07
CY1368A (en) 1987-08-07
SG30987G (en) 1987-07-17
IT1209867B (it) 1989-08-30
DK155976B (da) 1989-06-12
IE810989L (en) 1981-11-06
DE3117756C2 (fr) 1992-11-26
AU7020581A (en) 1981-11-12

Similar Documents

Publication Publication Date Title
DE3329265C2 (fr)
DE69521328T2 (de) Kaffein-formulierung mit verzögerter freisetzung
DE1617374C2 (de) Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung
DE3880762T2 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE60207383T2 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
DE69826290T2 (de) Pharmazeutische zusammensetzungen zur kontrollierten freigabe von wirkstoffen
DE3309516C2 (fr)
DE3887179T2 (de) Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
DE69313983T2 (de) Ein Guanidinothiazol und Antazida enthaltende Arzneimittel
DE69422861T2 (de) Pharmazeutische Zusammensetzung mit kontrollierter Freigabe auf Grund von einer oder mehrerer pharmazeutischer verträglicher Salze von Gamma-Hydroxybuttersäure
DE60225331T2 (de) Pharmazeutische zusammensetzungen mit metformin und glibenclamid zur behandlung von diabetes mellitus typ ii
DE2611041C2 (fr)
DE69829042T2 (de) Nicotinsäurezusammensetzungen enthaltender Starterkit
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE3435040A1 (de) Pharmazeutische zusammensetzung, geeignet zur behandlung von hang-over-symptomen
DE3435325A1 (de) Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
EP0250648B1 (fr) Préparation pharmaceutique pour la libération retardée de l'ibuprofène
AT389226B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE3719818C2 (de) Pharmazeutische Zusammensetzung
DE3117756C2 (fr)
DE69103624T2 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE3733540A1 (de) Eine pharmazeutische zusammensetzung mit verzoegerter freigabe des wirkstoffes
DE3528481A1 (de) Neues pharmazeutisches praeparat
DE3040042A1 (de) Pharmazeutische zubereitung des tiaramids oder seiner pharmazeutisch vertraeglichen salze

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA

8128 New person/name/address of the agent

Representative=s name: KINZEBACH, W., DIPL.-CHEM. DR.PHIL. RIEDL, P., DIP

D2 Grant after examination
8364 No opposition during term of opposition